Literature DB >> 21424697

Helicobacter pylori negative, non-steroidal anti-inflammatory drug-negative peptic ulcers in India.

Mahesh Kumar Goenka1, Shounak Majumder, Pradeepta Kumar Sethy, Madhurima Chakraborty.   

Abstract

INTRODUCTION: The past decade has witnessed a global rise in the prevalence of peptic ulcer disease which is unrelated to non-steroidal anti-inflammatory drugs (NSAIDs) or Helicobacter pylori infection. Although initially recognized in the West, this disease is being increasingly recognized in the Asian population. The higher risk of bleeding and ulcer recurrence in this subgroup of patients highlights the clinical importance of analyzing the changing trends of peptic ulcer disease in developing countries. AIMS: To assess the proportion of non-NSAID, non-H. pylori peptic ulcer disease in an Indian cohort of patients with peptic ulcer disease managed at a tertiary care center; and to compare the gastric and duodenal ulcer subgroups in these patients.
METHODS: Patients diagnosed with peptic ulcer disease were screened for a history of NSAID use and those with a negative history were tested for H. pylori using a combination of rapid urease test (RUT) and (14)C-urea breath test (UBT). Only those cases which tested negative for both the tests were considered 'H. pylori-negative'. Serum gastrin was measured in all patients included in the study.
RESULTS: Seventy-four gastric ulcer (GU) and 54 duodenal ulcer (DU) patients with no history of NSAID use were enrolled. Of these, 36 GU (45.9%) and 16 DU (29.6%) patients were H. pylori-negative. The proportion of non-NSAID non-H. pylori gastric ulcers was significantly higher than duodenal ulcers (p < 0.05). However, patients who tested negative for H. pylori did not differ significantly from those who tested positive with regard to age, gender, serum gastrin level, and presence of risk factors, like smoking and alcoholism.
CONCLUSION: The current study indicates existence of high proportion of non-NSAID, non-H. pylori peptic ulcer disease in Indian patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21424697     DOI: 10.1007/s12664-011-0085-9

Source DB:  PubMed          Journal:  Indian J Gastroenterol        ISSN: 0254-8860


  32 in total

1.  Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report.

Authors:  P Malfertheiner; F Megraud; C O'Morain; F Bazzoli; E El-Omar; D Graham; R Hunt; T Rokkas; N Vakil; E J Kuipers
Journal:  Gut       Date:  2006-12-14       Impact factor: 23.059

2.  Clinical presentation of peptic ulcer in the elderly.

Authors:  H Kemppainen; I Räihä; L Sourander
Journal:  Gerontology       Date:  1997       Impact factor: 5.140

Review 3.  Is Helicobacter pylori the primary cause of duodenal ulceration?

Authors:  F I Tovey; M Hobsley
Journal:  J Gastroenterol Hepatol       Date:  1999-11       Impact factor: 4.029

4.  Risk factors for duodenal ulcer in north India.

Authors:  A Jain; S Buddhiraja; B Khurana; R Singhal; D Nair; P Arora; P Gangwal; S K Mishra; B Uppal; R Gondal; P Kar
Journal:  Trop Gastroenterol       Date:  1999 Jan-Mar

5.  Prevalence of Helicobacter pylori in peptic ulcer disease in a Singapore hospital.

Authors:  C Vu; Y Y Ng
Journal:  Singapore Med J       Date:  2000-10       Impact factor: 1.858

6.  Epidemiology of Helicobacter pylori and peptic ulcer in India.

Authors:  Virendra Singh; Bandana Trikha; Chander Kanwal Nain; Kartar Singh; Kim Vaiphei
Journal:  J Gastroenterol Hepatol       Date:  2002-06       Impact factor: 4.029

Review 7.  How I manage H. pylori-negative, NSAID/aspirin-negative peptic ulcers.

Authors:  Kenneth E L McColl
Journal:  Am J Gastroenterol       Date:  2009-01       Impact factor: 10.864

Review 8.  Management of peptic ulcer disease not related to Helicobacter pylori or NSAIDs.

Authors:  Carolyn Quan; Nicholas J Talley
Journal:  Am J Gastroenterol       Date:  2002-12       Impact factor: 10.864

Review 9.  Non-NSAID non-H. pylori ulcer disease.

Authors:  Dorothy K L Chow; Joseph J Y Sung
Journal:  Best Pract Res Clin Gastroenterol       Date:  2009       Impact factor: 3.043

10.  The prevalence of peptic ulcer not related to Helicobacter pylori or non-steroidal anti-inflammatory drug use is negligible in southern Europe.

Authors:  M Teresa Arroyo; Montse Forne; Carlos Martin de Argila; Faust Feu; Juan Arenas; Juan de la Vega; Vicente Garrigues; Francisco Mora; Manuel Castro; Luis Bujanda; Angel Cosme; Agustín Castiella; Javier P Gisbert; Antonio Hervas; Angel Lanas
Journal:  Helicobacter       Date:  2004-06       Impact factor: 5.753

View more
  9 in total

Review 1.  Helicobacter pylori-negative, non-steroidal anti-inflammatory drug: negative idiopathic ulcers in Asia.

Authors:  Katsunori Iijima; Takeshi Kanno; Tomoyuki Koike; Tooru Shimosegawa
Journal:  World J Gastroenterol       Date:  2014-01-21       Impact factor: 5.742

2.  The Role of Helicobacter pylori and NSAIDs in the Pathogenesis of Uncomplicated Duodenal Ulcer.

Authors:  Ayhan Hilmi Cekin; Muharrem Taskoparan; Adil Duman; Cem Sezer; Yesim Cekin; Basak Oguz Yolcular; Hasan Can; Fatma Seher Pehlivan; Mine Cayirci
Journal:  Gastroenterol Res Pract       Date:  2012-09-25       Impact factor: 2.260

Review 3.  A systematic approach for the diagnosis and treatment of idiopathic peptic ulcers.

Authors:  Chen-Shuan Chung; Tsung-Hsien Chiang; Yi-Chia Lee
Journal:  Korean J Intern Med       Date:  2015-08-27       Impact factor: 2.884

4.  Optimized Ellagic Acid-Ca Pectinate Floating Beads for Gastroprotection against Indomethacin-Induced Gastric Injury in Rats.

Authors:  Nabil A Alhakamy; Shaimaa M Badr-Eldin; Osama A A Ahmed; Abdulrahman A Halwani; Hibah M Aldawsari; Mohamed A El-Moselhy; Aliaa Anter; Sara S Sharkawi; Muhammad H Sultan; Osama A A Madkhali; Muhammed A Bakhrebah; Mohammad N Alomary; Wesam H Abdulaal; Usama A Fahmy
Journal:  Biomolecules       Date:  2020-07-06

Review 5.  Helicobacter pylori: Commensal, symbiont or pathogen?

Authors:  Vasiliy Ivanovich Reshetnyak; Alexandr Igorevich Burmistrov; Igor Veniaminovich Maev
Journal:  World J Gastroenterol       Date:  2021-02-21       Impact factor: 5.742

6.  High Recurrence Rate of Idiopathic Peptic Ulcers in Long-Term Follow-up.

Authors:  Hyuk Yoon; Sang Gyun Kim; Hyun Chae Jung; In Sung Song
Journal:  Gut Liver       Date:  2013-03-14       Impact factor: 4.519

7.  Inhibitory Effects of ECQ on Indomethacin-Induced Gastric Damage in Rats.

Authors:  Juho Jung; Yoonjin Nam; Uy Dong Sohn
Journal:  Korean J Physiol Pharmacol       Date:  2012-12-10       Impact factor: 2.016

8.  Prevalence of Helicobacter Pylori-Negative, Non-Steroidal Anti-Inflammatory Drug Related Peptic Ulcer Disease in Patients Referred to Afzalipour Hospital.

Authors:  Seyed Mahdi Seyed Mirzaei; Mohammad Javad Zahedi; Sara Shafiei Pour
Journal:  Middle East J Dig Dis       Date:  2015-10

9.  Non-Helicobacter pylori, non-NSAIDs peptic ulcers: a descriptive study on patients referred to Taleghani hospital with upper gastrointestinal bleeding.

Authors:  Hasan Rajabalinia; Mehdi Ghobakhlou; Shahriar Nikpour; Reza Dabiri; Rasoul Bahriny; Somayeh Jahani Sherafat; Pardis Ketabi Moghaddam; Amirhoushang Mohammad Alizadeh
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2012
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.